Articles by Dr Simon Stott

Cure Parkinson’s Autumn Research Update meeting – 2023

Cure Parkinson’s Autumn Research Update meeting – 2023

Cure Parkinson’s is a medical research charity that is focused on disease modification for Parkinson’s. Our only goal is to slow, stop or reverse the condition. To achieve this aim, we fund and support preclinical projects (that are with 5 years of clinical testing) and clinical trials focused on testing new […]

The UP Study results

The UP Study results

Preclinical data have suggested that the bile acid Ursodeoxycholic acid (or UDCA) has neuroprotective properties in models of Parkinson’s. Researchers in Sheffield have led much of this research and they have also been coordinating a clinical trial assessing this molecule in people with Parkinson’s. The study was called the “UDCA in […]

Just a lysosomal enzyme…

Just a lysosomal enzyme…

About 5% of individuals affected by Parkinson’s carry a genetic variation in a region of their DNA called the GBA1 gene. This area of DNA provides the instructions for making an enzyme called GCase, which is known to be involved in cellular waste disposal. Recently, however, researchers have discovered that GCase […]

Year in review: 2022

Year in review: 2022

At the end of each year, it is a useful process to take stock and review what we have learnt over the last 12 months. 2022 has been an extremely busy year for Parkinson’s research, with a lot of clinical trial results and new insights. As the world continues to re-open […]

Load more